Dual-channel red/blue fluorescence dosimetry with broadband reflectance spectroscopic correction measures protoporphyrin IX production during photodynamic therapy of actinic keratosis

Journal of Biomedical Optics

Volumn 19, Issue 7, 2014, Pages

  Kanick, Stephen Chad ^a   Davis, Scott C ^a   Zhao, Yan ^a   Hasan, Tayyaba ^b   Maytin, Edward V ^c   Pogue, Brian W ^a,b,d   Chapman, M Shane ^d  

^a DARTMOUTH COLLEGE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

dosimetry; fluorescence; optical spectroscopy; pharmacokinetics; photodynamic therapy; protoporphyrin IX.; reflectance

Indexed keywords

DOSIMETERS; DOSIMETRY; PHARMACOKINETICS; PHOTODYNAMIC THERAPY; REFLECTION; SPECTROMETERS;

AMINOLEVULINIC ACID; CORRECTION MEASURES; OPTICAL SPECTROSCOPY; PROTOPORPHYRIN IX; REDUCED SCATTERING COEFFICIENTS; STANDARDIZED METHODS; WAVELENGTH EXCITATIONS; WHITE LIGHT SPECTROSCOPY;

FLUORESCENCE;

PROTOPORPHYRIN;

HUMAN; IMAGE QUALITY; KERATOSIS, ACTINIC; METABOLISM; PHOTOCHEMOTHERAPY; PILOT STUDY; PROCEDURES; RADIOMETRY; REPRODUCIBILITY; SPECTROFLUOROMETRY;

HUMANS; KERATOSIS, ACTINIC; PHANTOMS, IMAGING; PHOTOCHEMOTHERAPY; PILOT PROJECTS; PROTOPORPHYRINS; RADIOMETRY; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, FLUORESCENCE;

EID: 84925008418     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.19.7.075002     Document Type: Article

References (48)

1. E. W. Jeffes, "Levulan: the first approved topical photosensitizer for the treatment of actinic keratosis," J. Dermatol. Treat. 13(Suppl 1), S19-23 (2002). (Pubitemid 34665810)
2. S. R. Feldman and A. B. Fleischer Jr., "Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications," Cutis 87(4), 201-207 (2011).
3. E. W. Jeffes et al., "Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light," J. Am. Acad. Dermatol. 45(1), 96-104 (2001). (Pubitemid 32655701)
4. D. J. Piacquadio et al., "Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials," Arch. Dermatol. 140(1), 41-46 (2004). (Pubitemid 38090269)
5. E. H. Tschen et al, "Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up," Br. J. Dermatol. 155(6), 1262-1269 (2006).
6. J. C. Kennedy and R. H. Pottier, "Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy," J. Photochem. Photobiol. B Biol. 14(4), 275-292 (1992).
7. T. Smits et al., "Correlation between macroscopic fluorescence and protoporphyrin IX content in psoriasis and actinic keratosis following application of aminolevulinic acid," J. Investig. Dermatol. 125(4), 833-839 (2005).
8. M. Tarstedt et al., "A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp," Actadermato-venereologica 85(5), 424-428 (2005). (Pubitemid 41345617)
9. Q. Peng et al., "Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate, " J. Photochem. Photobiol. B Biol. 62(3), 140-145 (2001). (Pubitemid 32898834)
10. S. Smith et al., "Short incubation PDT versus 5-FU in treating actinic keratoses," J. Drugs Dermatol. 2(6), 629-635 (2003).
11. L. R. Braathen et al., "Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses," J. Eur. Acad. Dermatol. Venereol. 23(5), 550-555 (2009).
12. R. Bissonnette et al., "Short incubation photodynamic therapy with methylaminolevulinate and no occlusion for the treatment of actinic keratoses," J. Am. Acad. Dermatol. 67(6), 1386-1387 (2012).
13. D. Touma et al., "A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage," Arch. Dermatol. 140(1), 33-40 (2004). (Pubitemid 38090268)
14. C. Fritsch et al., "Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid," Br. J. Cancer 79(9-10), 1603-1608 (1999). (Pubitemid 29116827)
15. A. L. Golub et al., "The monitoring of ALA-induced protoporphyrin IX accumulation and clearance in patients with skin lesions by in vivo surface-detected fluorescence spectroscopy," Laser Med. Sci 14(2), 112-122 (1999).
16. A. K. Sinha et al., "Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells," Br. J. Cancer 95(4), 485-495 (2006). (Pubitemid 44232558)
17. M. J. Gerritsen et al., "Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy," Dermatology 218(3), 193-202 (2009).
18. B. C. Wilson, M. S. Patterson, and L. Lilge, "Implicit and explicit dosimetry in photodynamic therapy: a new paradigm," Lasers Med. Sci. 12(3), 182-199 (1997). (Pubitemid 27404122)
19. C. Sheng et al., "Photobleaching-based dosimetry predicts deposited dose in ALA-PpIX PDT of rodent esophagus," Photochem. Photobiol. 83(3), 738-748 (2007).
20. K. R. Rollakanti et al., "Techniques for fluorescence detection of protoprophyrin IX in skin cancers associated with photodynamic therapy," Photon Lasers Med 2(4), 287-303 (2013).
21. K. Rick et al., "Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood," J. Photochem. Photobiol. B 40(3), 313-319 (1997). (Pubitemid 27478319)
22. J. Hewett et al., "The application of a compact multispectral imaging system with integrated excitation source to in vivo monitoring of fluorescence during topical photodynamic therapy of superficial skin cancers," Photochem. Photobiol. 73(3), 278-282 (2001).
23. S. H. Ibbotson et al., "Characteristics of 5-aminolaevulinic acid-induced protoporphyrin IX fluorescence in human skin in vivo," Photodermatol. Photoimmunol. Photomed. 22(2), 105-110 (2006). (Pubitemid 44056529)
24. C. B. Warren et al., "Noninvasive fluorescence monitoring of protoporphyrin IX production and clinical outcomes in actinic keratoses following short-contact application of 5-aminolevulinate," J. Biomed. Opt. 15(5), 051607 (2010).
25. F. Piffaretti et al., "Correlation between protoporphyrin IX fluorescence intensity, photobleaching, pain and clinical outcome of actinic keratosis treated by photodynamic therapy," Dermatology 227(3), 214-225 (2013).
26. B. W. Pogue and G. Burke, "Fiber-optic bundle design for quantitative fluorescence measurement from tissue," Appl. Opt. 37(31), 7429-7436 (1998). (Pubitemid 128659489)
27. A. Amelink et al., "Quantitative fluorescence spectroscopy in turbid media using fluorescence differential path length spectroscopy," J. Biomed. Opt. 13(5), 054051 (2008).
28. S. C. Kanick et al., "Extraction of intrinsic fluorescence from single fiber fluorescence measurements on a turbid medium," Opt. Lett. 37(5), 948-950 (2012).
29. A. Kim et al., "Quantification of in vivo fluorescence decoupled from the effects of tissue optical properties using fiber-optic spectroscopy measurements," J. Biomed. Opt. 15(6), 067006 (2010).
30. S. L. Jacques, "Optical properties of biological tissues: a review," Phys. Med. Biol. 58(11), R37-61 (2013).
31. P. A. Valdes et al., "A spectrally constrained dual-band normalization technique for protoporphyrin IX quantification in fluorescence-guided surgery," Opt. Lett. 37(11), 1817-1819 (2012).
32. R. B. Saager et al., "Quantitative fluorescence imaging of protoporphyrin IX through determination of tissue optical properties in the spatial frequency domain," J. Biomed. Opt. 16(12), 126013 (2011).
33. U. Sunar et al., "Quantification of PpIX concentration in basal cell carcinoma and squamous cell carcinoma models using spatial frequency domain imaging," Biomed. Opt. Express 4(4), 531-537 (2013).
34. B. P. Flynn et al., "White light-informed optical properties improve ultrasound-guided fluorescence tomography of photoactive protoporphyrin IX," J. Biomed. Opt. 18(4), 046008 (2013).
35. T. L. Becker et al., "Monitoring blood flow responses during topical ALA-PDT," Biomed. Opt. Express 2(1), 123-130 (2010).
36. T. A. Middelburg et al., "Monitoring blood volume and saturation using superficial fibre optic reflectance spectroscopy during PDT of actinic keratosis," J. Biophotonics 4(10), 721-730 (2011).
37. S. C. Kanick et al., "Scattering phase function spectrum makes reflectance spectrum measured from Intralipid phantoms and tissue sensitive to the device detection geometry," Biomed. Opt. Express 3(5), 1086-1100 (2012).
38. R. Michels, F. Foschum, and A. Kienle, "Optical properties of fat emulsions," Opt. Express 16(8), 5907-5925 (2008). (Pubitemid 351544212)
39. N. Rajaram et al., "Experimental validation of the effects of microvasculature pigment packaging on in vivo diffuse reflectance spectroscopy," Lasers Surg. Med. 42(7), 680-688 (2010).
40. I. V. Meglinski and S. J. Matcher, "Quantitative assessment of skin layers absorption and skin reflectance spectra simulation in the visible and near-infrared spectral regions," Physiol. Meas. 23(4), 741-753 (2002). (Pubitemid 35386579)
41. A. Amelink, D. J. Robinson, and H. J. Sterenborg, "Confidence intervals on fit parameters derived from optical reflectance spectroscopy measurements," J. Biomed. Opt. 13(5), 054044 (2008).
42. J. C. Finlay et al., "Porphyrin bleaching and PDT-induced spectral changes are irradiance dependent in ALA-sensitized normal rat skin in vivo," Photochem. Photobiol. 73(1), 54-63 (2001).
43. E. Hull et al., "Noninvasive, optical detection of diabetes: model studies with porcine skin," Opt. Express 12(19), 4496-4510 (2004).
44. R. Weersink et al., "Noninvasive measurement of fluorophore concentration in turbid media with a simple fluorescence/reflectance ratio technique," Appl. Opt. 40(34), 6389-6395 (2001).
45. B. Kruijt et al., "Monitoring ALA-induced PpIX photodynamic therapy in the rat esophagus using fluorescence and reflectance spectroscopy," Photochem. Photobiol. 84(6), 1515-1527 (2008).
46. A. K. Glaser et al., "A GAMOS plug-in for GEANT4 based Monte Carlo simulation of radiation-induced light transport in biological media," Biomed. Opt. Express 4(5), 741-759 (2013).
47. S. K. Attili, R. Dawe, and S. Ibbotson, "A review of pain experienced during topical photodynamic therapy-our experience in Dundee," Photodiagnosis Photodyn. Ther. 8(1), 53-57 (2011).
48. S. Fabricius et al., "The relation between methyl aminolevulinate concentration and inflammation after photodynamic therapy in healthy volunteers," Photochem. Photobiol. Sci. 12(1), 117-123 (2013).